id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-D-1445-0062,FDA,FDA-2013-D-1445,"Blood Glucose Monitoring Test Systems for Prescription Point-of-Care
Use; Guidance for Industry and Food and Drug Administration Staff;
Availability",Notice,Notice of Availability,2016-10-11T04:00:00Z,2016,10,2016-10-11T04:00:00Z,,2016-10-11T15:17:52Z,2016-24430,0,0,09000064822d1a6d
FDA-2013-D-1445-0063,FDA,FDA-2013-D-1445,Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Guidance for Industry and Food and Drug Administration Staff,Other,Guidance,2016-10-11T04:00:00Z,2016,10,2016-10-11T04:00:00Z,,2024-11-11T21:32:39Z,,1,0,09000064822dd986